21st Century Innovative Technologies and Developments as also discoveries, curiosity ( insolite)...

Pancreatic Cancer Vaccine Shows Promise in Small Trial
Using mRNA tailored to each patient’s tumor, the vaccine may have staved off the return of one of the deadliest forms of cancer in half of those who received it.

Learn more / En savoir plus / Mehr erfahren:

https://www.scoop.it/t/21st-century-innovative-technologies-and-developments/?&tag=Cancer

https://www.scoop.it/topic/21st-century-innovative-technologies-and-developments/?&tag=Research

Stool tests might provide a useful way to help doctors spot early pancreatic cancer, say researchers.

They have been trialling the concept in a study with 136 volunteers.

The findings, described in the journal Gut, suggest detectable changes involving gut bugs could provide a warning sign that a tumour is present.

Pancreatic cancer often doesn't cause symptoms in the early stages. That means it is usually more advanced and harder to treat when it is found.

As the cancer grows it may cause vague symptoms, such as indigestion, changes to bowel habit and some tummy or back pain. Some people see their GP several times before being diagnosed.

Learn more / En savoir plus / Mehr erfahren:

https://www.scoop.it/t/21st-century-innovative-technologies-and-developments/?&tag=Cancer

Den Wissenschaftlern ist es gelungen, mithilfe einer Künstlichen Intelligenz (KI) Menschen mit dem höchsten Risiko für Bauchspeicheldrüsenkrebs ausfindig zu machen - und das bis zu drei Jahre vor der Diagnose. „KI sagt zukünftigen Bauchspeicheldrüsenkrebs voraus“, titelt die Harvard Medcial School ihre Mitteilung zur Studie. Dafür benötige das Modell lediglich die Krankendaten der Patienten.

Learn more / En savoir plus / Mehr erfahren:

https://www.scoop.it/t/21st-century-innovative-technologies-and-developments/?&tag=Cancer

https://www.scoop.it/topic/21st-century-innovative-technologies-and-developments/?&tag=Research

Israeli scientists say a new study has shown that a small molecule called PJ34 has triggered the self-destruction of human pancreatic cancer cells in mice. According to the research, published in the peer-reviewed open-access biomedical journal Oncotarget, the administration of the molecule reduced the number of cancer cells in developed tumors by up to 90 percent in 30 days.

The study was led by Professor Malka Cohen-Armon and her team at Tel Aviv University’s Sackler Faculty of Medicine, in collaboration with Dr. Talia Golan and her team at the Cancer Research Center at Sheba Medical Center, and conducted with transplantations of human pancreatic cancer cells into immunocompromised mice, or xenografts.

Learn more / En savoir plus / Mehr erfahren:

https://www.scoop.it/t/21st-century-innovative-technologies-and-developments/?&tag=Cancer